151 related articles for article (PubMed ID: 25065301)
1. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A
Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301
[TBL] [Abstract][Full Text] [Related]
2. Low-rate repetitive nerve stimulation protocol in an Italian cohort of patients affected by recessive myotonia congenita.
Modoni A; D'Amico A; Dallapiccola B; Mereu ML; Merlini L; Pagliarani S; Pisaneschi E; Silvestri G; Torrente I; Valente EM; Lo Monaco M
J Clin Neurophysiol; 2011 Feb; 28(1):39-44. PubMed ID: 21221019
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine.
Ceccarelli M; Rossi B; Siciliano G; Calevro L; Tarantino E
Acta Paediatr; 1992 May; 81(5):453-5. PubMed ID: 1498517
[TBL] [Abstract][Full Text] [Related]
4. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy.
Jackson CE; Barohn RJ; Ptacek LJ
Muscle Nerve; 1994 Jul; 17(7):763-8. PubMed ID: 8008003
[TBL] [Abstract][Full Text] [Related]
5. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
Pouget J; Serratrice G
Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes.
Desaphy JF; Gramegna G; Altamura C; Dinardo MM; Imbrici P; George AL; Modoni A; Lomonaco M; Conte Camerino D
Exp Neurol; 2013 Oct; 248():530-40. PubMed ID: 23933576
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel slow inactivation as a therapeutic target for myotonia congenita.
Novak KR; Norman J; Mitchell JR; Pinter MJ; Rich MM
Ann Neurol; 2015 Feb; 77(2):320-32. PubMed ID: 25515836
[TBL] [Abstract][Full Text] [Related]
9. Decrement of compound muscle action potential is related to mutation type in myotonia congenita.
Colding-Jørgensen E; DunØ M; Schwartz M; Vissing J
Muscle Nerve; 2003 Apr; 27(4):449-55. PubMed ID: 12661046
[TBL] [Abstract][Full Text] [Related]
10. Transient weakness and compound muscle action potential decrement in myotonia congenita.
Deymeer F; Cakirkaya S; Serdaroğlu P; Schleithoff L; Lehmann-Horn F; Rüdel R; Ozdemir C
Muscle Nerve; 1998 Oct; 21(10):1334-7. PubMed ID: 9736066
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological evaluation of congenital myotonia.
Rossi B; Siciliano G; Sartucci F
Electromyogr Clin Neurophysiol; 1985; 25(6):413-22. PubMed ID: 4065028
[No Abstract] [Full Text] [Related]
12. Myotonia congenita--a cause of muscle weakness and stiffness.
Chrestian N; Puymirat J; Bouchard JP; Dupré N
Nat Clin Pract Neurol; 2006 Jul; 2(7):393-9; quiz following 399. PubMed ID: 16932590
[TBL] [Abstract][Full Text] [Related]
13. Treatment of myotonia with antiarrhythmic drugs.
Kwieciński H; Ryniewicz B; Ostrzycki A
Acta Neurol Scand; 1992 Oct; 86(4):371-5. PubMed ID: 1455983
[TBL] [Abstract][Full Text] [Related]
14. Transient muscular weakness in severe recessive myotonia congenita. Improvement of isometric muscle force by drugs relieving myotomic stiffness.
Ricker K; Haass A; Hertel G; Mertens HG
J Neurol; 1978 Aug; 218(4):253-62. PubMed ID: 81274
[TBL] [Abstract][Full Text] [Related]
15. [Value of mexiletine in the treatment of Thomsen-Becker myotonia].
Leheup B; Himon F; Morali A; Brichet F; Vidailhet M
Arch Fr Pediatr; 1986 Jan; 43(1):49-50. PubMed ID: 3707279
[TBL] [Abstract][Full Text] [Related]
16. Unusual causes of stiffness in two hockey players.
Burnham R
Clin J Sport Med; 1997 Apr; 7(2):137-40. PubMed ID: 9113432
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing paramyotonia congenita and myotonia congenita by electromyography.
Subramony SH; Malhotra CP; Mishra SK
Muscle Nerve; 1983 Jun; 6(5):374-9. PubMed ID: 6888415
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of myotonia congenita].
Rossi B; Sartucci F; Siciliano G
Minerva Pediatr; 1986 Aug; 38(15-16):673-8. PubMed ID: 3796521
[No Abstract] [Full Text] [Related]
19. Electrical myotonia in heterozygous carriers of recessive myotonia congenita.
Deymeer F; Lehmann-Horn F; Serdaroğlu P; Cakirkaya S; Benz S; Rüdel R; Ozdemir C
Muscle Nerve; 1999 Jan; 22(1):123-5. PubMed ID: 9883868
[TBL] [Abstract][Full Text] [Related]
20. Focal and abnormally persistent paralysis associated with congenital paramyotonia.
Magot A; David A; Sternberg D; Péréon Y
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24939454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
